Literature DB >> 31122879

The prevalence of Staphylococcus aureus with mucoid phenotype in the airways of patients with cystic fibrosis-A prospective study.

Farina E Lennartz1, Bianca Schwartbeck1, Angelika Dübbers2, Jörg Große-Onnebrink2, Christina Kessler2, Peter Küster3, Holger Schültingkemper3, Georg Peters1, Barbara C Kahl4.   

Abstract

BACKGROUND: Staphylococcus aureus is one of the most frequently isolated pathogens in the respiratory tract of CF patients. Recently, we characterized peculiar mucoid S. aureus isolates, which are excessive biofilm formers and which carried a 5bp-deletion within the intergenic region of the ica operon. In this prospective study, we determined the prevalence of mucoid S. aureus-isolates in the airways of CF-patients during a 3-months period.
METHODS: We analyzed specimens (sputa, throat swabs) from 81 CF patients who attended two CF centers in Münster, Germany. Ten S. aureus isolates were randomly picked from every S. aureus-positive airway specimen and evaluated for mucoidy using Congo Red agar and phenotypic tests. Mucoid isolates were characterized by spa sequence typing, biofilm production and sequencing of the intergenic region of the ica operon to screen for the 5bp-deletion.
RESULTS: In 7 of 81 examined patients (8.6%), we detected mucoid S. aureus phenotypes (37 out of 1050 isolates; 3.5%). Twenty-five mucoid isolates carried the 5bp-deletion. Mucoid isolates produced excessive biofilm and were significantly more resistant to certain antibiotics.
CONCLUSIONS: In our prospective study, mucoid S. aureus was present in 8.6% of S. aureus-positive CF-patients. In 6 of 7 patients, mucoid isolates carried the 5bp-deletion, indicating that also other so far not identified mechanisms cause excessive biofilm formation. Further studies are necessary to ascertain the clinical impact of mucoid S. aureus phenotypes on the severity of the CF disease.
Copyright © 2019. Published by Elsevier GmbH.

Entities:  

Keywords:  Biofilm; Cystic fibrosis; Ica; Mucoid phenotype; S. aureus

Mesh:

Substances:

Year:  2019        PMID: 31122879     DOI: 10.1016/j.ijmm.2019.05.002

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  4 in total

1.  Genomic analysis of Staphylococcus aureus from the West African Dwarf (WAD) goat in Nigeria.

Authors:  Adebayo Osagie Shittu; Fadekemi Funmilayo Taiwo; Neele Judith Froböse; Bianca Schwartbeck; Silke Niemann; Alexander Mellmann; Frieder Schaumburg
Journal:  Antimicrob Resist Infect Control       Date:  2021-08-19       Impact factor: 4.887

2.  Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.

Authors:  Eryn E Bernardy; Robert A Petit; Vishnu Raghuram; Ashley M Alexander; Timothy D Read; Joanna B Goldberg
Journal:  mBio       Date:  2020-06-23       Impact factor: 7.867

Review 3.  Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms.

Authors:  Lloyd S Miller; Vance G Fowler; Sanjay K Shukla; Warren E Rose; Richard A Proctor
Journal:  FEMS Microbiol Rev       Date:  2020-01-01       Impact factor: 16.408

4.  Association of Diverse Staphylococcus aureus Populations with Pseudomonas aeruginosa Coinfection and Inflammation in Cystic Fibrosis Airway Infection.

Authors:  Marie K Wieneke; Felix Dach; Claudia Neumann; Dennis Görlich; Lena Kaese; Theo Thißen; Angelika Dübbers; Christina Kessler; Jörg Große-Onnebrink; Peter Küster; Holger Schültingkemper; Bianca Schwartbeck; Johannes Roth; Jerzy-Roch Nofer; Janina Treffon; Julia Posdorfer; Josefine Marie Boecken; Mariele Strake; Miriam Abdo; Sophia Westhues; Barbara C Kahl
Journal:  mSphere       Date:  2021-06-23       Impact factor: 4.389

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.